Alquraishi Ali, Alshahrany Abdullah, Alasmari Badriah G, Hommadi Ashwaq, Alomari Mohammed
Pediatric Endocrinology, Armed Forces Hospital Southern Region, Khamis Mushait, SAU.
Pediatrics, Armed Forces Hospital Southern Region, Khamis Mushait, SAU.
Cureus. 2024 Aug 19;16(8):e67165. doi: 10.7759/cureus.67165. eCollection 2024 Aug.
Pseudohypoaldosteronism type 1 (PHA1) is a rare, heterogeneous group of disorders characterized by resistance to aldosterone action. We report the case of a 17-day-old Saudi female infant who presented on the third day of life with persistent hyperkalemia, hyponatremia, and metabolic acidosis. Initial evaluation for congenital adrenal hyperplasia was unremarkable. Genetic testing confirmed a novel homozygous variant (c.1522C>T p.(Arg508) chr 12:6458147 in SCNN1 A) in the gene, consistent with the diagnosis of PHA1B, a genetically confirmed subtype of PHA1. Prompt recognition and management of electrolyte disturbances are crucial in these neonates to prevent life-threatening complications.
1型假性醛固酮增多症(PHA1)是一组罕见的异质性疾病,其特征为对醛固酮作用产生抵抗。我们报告了一例17日龄的沙特女婴病例,该女婴在出生第三天出现持续性高钾血症、低钠血症和代谢性酸中毒。对先天性肾上腺增生的初步评估无异常。基因检测证实该基因存在一种新的纯合变异(c.1522C>T p.(Arg508) chr 12:6458147 in SCNN1 A),与PHA1的基因确诊亚型PHA1B的诊断一致。对于这些新生儿,及时识别和处理电解质紊乱对于预防危及生命的并发症至关重要。